Tykerb 250 MG Tablet
| Brand Name | Tykerb |
|---|---|
| Composition (Generic / INN) | Lapatinib Ditosylate Monohydrate |
| Strength | 250 mg |
| Packaging Size | 30 Tablets |
| Packaging Type | Bottle |
| Dosage Form | Tablets |
| Manufacturer | Novartis |
| Prescription / Non-Prescription | Non-Prescription |
| Usage / Indication | Treatment of breast cancer |
Product Overview
Tykerb 250 MG Tablet contains Lapatinib Ditosylate Monohydrate and is formulated as a 250 mg oral tablet. It is supplied in a bottle of 30 tablets and is used in the treatment of breast cancer. Manufactured by Novartis, this product is a trusted option for oncology supply chains.
Product Specifications
- Brand: Tykerb
- Composition: Lapatinib Ditosylate Monohydrate
- Strength: 250 mg
- Form: Tablets
- Pack Size: 30 Tablets
- Pack Type: Bottle
- Manufacturer: Novartis
- Prescription Status: Non-Prescription
- Therapeutic Category: Oncology & Cytotoxics
Quality & Handling
All products are sourced through authorized channels and handled in compliance with standard pharmaceutical export practices to maintain product integrity during transit.
Supply & Export
Gravity Global Export supplies authentic Tykerb tablets to licensed distributors, hospitals, pharmacies, and importers across global markets. We offer competitive B2B pricing, bulk procurement options, and dependable logistics support with proper export documentation. Reach out today to request a quotation and check current stock availability.
Interested in this product?
Tell us your quantity and destination — our export team replies with a competitive quotation.